Pu Chuanqiang

[Expert Profile] Pu Chuanqiang, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in neuromuscular and neuroimmune diseases in China, working in the Department of Neurology, Chinese PLA General Hospital (301 Hospital). He has long been dedicated to the clinical diagnosis, treatment, and basic research of neuromuscular junction diseases such as myasthenia gravis and Lambert-Eaton myasthenic syndrome, and is an important expert in neuroimmunology in China.

[Education & Career] Professor Pu Chuanqiang graduated from a military medical university, completed systematic clinical and research training in the Department of Neurology at the Chinese PLA General Hospital, and further studied at famous international neurology centers. He has long been engaged in clinical neurology work, holding important academic positions such as leader of the Neuromuscular Diseases Group of the Neurology Branch of the Chinese Medical Association. He has presided over grants from the National Natural Science Foundation of China and key military research projects, making important contributions to the development of neurology in both military and civilian healthcare systems.

[Areas of Expertise] Professor Pu specializes in the standardized diagnosis and treatment of neuromuscular junction diseases such as myasthenia gravis and Lambert-Eaton myasthenic syndrome, as well as comprehensive management of various inflammatory myopathies, peripheral neuropathies, and neuromuscular diseases. He has extensive experience in acetylcholine receptor antibody testing interpretation, thymoma-associated myasthenia gravis evaluation, and individualized application of immunosuppressants and biologics. He excels at managing critical situations such as myasthenic crisis, helping numerous patients with "drooping eyelids and limb weakness" identify the causes of their neuromuscular conditions, control disease progression, and recover function.

[Academic Achievements & Industry Contributions] Professor Pu has led a series of clinical studies on myasthenia gravis and neuromuscular diseases in Chinese populations, systematically evaluating the efficacy and safety of different treatment regimens, with findings published in authoritative domestic and international journals. He has led the development of Chinese myasthenia gravis diagnosis and treatment guidelines and expert consensus statements, actively promoted standardized diagnosis and application of novel targeted therapies, and led multi-center clinical trials. He has also dedicated himself to the development of military neurology and talent training, having trained a large number of neurology and neuromuscular disease specialists, significantly improving the overall diagnosis and treatment level of neuromuscular immune diseases in China.

[Clinical Practice & Outstanding Contributions] For decades on the clinical front lines, Professor Pu has treated tens of thousands of patients with myasthenia gravis and various neuromuscular diseases, including many difficult and severe cases who traveled from across the country to seek his care. With noble medical ethics and exceptional technical skill, he has successfully treated a large number of patients in myasthenic crisis, saving countless lives. He has received multiple military and national honors and awards, and is an outstanding representative in the field of neurology across the entire military system. His rigorous, pragmatic, and selfless dedication is deeply admired by patients and younger colleagues alike.

[Honors & Reputation] Professor Pu Chuanqiang serves as a standing committee member of the Neurology Branch of the Chinese Medical Association, among other academic positions. He has long been engaged in clinical and research work on neuromuscular and neuroimmune diseases, and is a senior authority in the field of myasthenia gravis in China. He has accumulated extensive experience in precise diagnosis, immunotherapy, and long-term management of neuromuscular junction diseases such as myasthenia gravis and Lambert-Eaton myasthenic syndrome. He has led research on comprehensive treatment of thymoma-associated myasthenia and refractory myasthenia, promoted the standardized clinical application of diagnostic techniques such as anti-acetylcholine receptor antibody testing, and participated in the development of Chinese myasthenia gravis diagnosis and treatment guidelines. He has helped numerous myasthenia gravis patients stabilize their conditions and return to normal life, trained a large number of neuroimmunology professionals, and is deeply trusted by patients.